Seattle Children's Hospital — Seattle, Washington

Public research footprint of Seattle Children's Hospital, compiled from the ClinicalTrials.gov public registry.

967

Registered studies

334

Active

186

Recruiting now

Stopped or withdrawn

Most-studied conditions

Classic Hodgkin Lymphoma · Botryoid-Type Embryonal Rhabdomyosarcoma · Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma · T-cell Acute Lymphoblastic Leukemia

Recently updated registry entries

NCT05099003 — A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed… (Recruiting)
NCT05543616 — A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy… (Completed)
NCT06514794 — A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Seattle Children's Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.